NovaMeds
Evidence-based guides to medicines, active ingredients and emerging research.
Complete guide to tirzepatide dosing across approved indications. Explains the step-by-step 4-week titration protocol from 2.5 mg to 15 mg, device handling (KwikPen vs vials), maintenance targets and rules for missed injections.
Discontinuing GLP-1 receptor agonists leads to substantial weight regain in clinical trials. Here is what the STEP-1 extension and SURMOUNT-4 studies reveal about metabolic adaptation, appetite recovery and long-term weight management.
Discover what peptides are, how peptide medicines work, and why approved therapies differ from investigational compounds such as BPC-157.